Joseph Arboleda-Velasquez (Courtesy of Mass Eye and Ear)

Sci­en­tists just dis­cov­ered a new ge­net­ic clue for de­lay­ing Alzheimer’s dis­ease. It’s al­ready in­spir­ing drug dis­cov­ery

Re­search on one of the most fa­mous fam­i­lies in neu­rol­o­gy has shed new light on the in­ter­play be­tween Alzheimer’s dis­ease and a rare gene that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA